文献速递眼整形与眼眶眼底病与葡萄膜炎

眼眶弥漫大B细胞淋巴瘤19例临床与组织病理学特征

[Clinical and histopathological characteristics of 19 cases of orbital diffuse large B-cell lymphoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2026-01-01

该回顾性病例系列研究纳入2016年1月至2024年12月确诊的19例(19只眼)眼眶弥漫大B细胞淋巴瘤患者,分析其临床表现、影像学及病理学特征。结果示多为中心母细胞型及非生发中心型,Ki67高表达及Bcl-2/C-MYC双表达比率较高,需积极治疗以降低病死率。

要点

  • O-DLBCL多表现为眼球突出、眼睑肿胀和眼球运动受限,影像学可呈浸润性生长。
  • 病理以中心母细胞型(15例)和非生发中心型(13例)为主,Ki67≥80%者13例。
  • Bcl-2和C-MYC双表达9例,需积极治疗以降低病死率。

核心结论

  • O-DLBCL多为中心母细胞型及非生发中心型,Ki67较高,Bcl-2和C-MYC双表达比率较高,需积极治疗以降低其病死率。

研究设计与样本

  • 回顾性病例系列研究,纳入2016年1月至2024年12月在西安市人民医院(西安市第四医院)陕西省眼科医院确诊的O-DLBCL患者19例(19只眼)。
  • 采用免疫组织化学EnVision法检测CD20、C-MYC、CD10、Bcl-2、Bcl-6、MUM1、P53及CD30等指标,根据Hans法分型,采用Fisher精确概率法进行数据分析。

主要发现

  • 19例中男性9例、女性10例,年龄56.0(50.3,63.0)岁(范围30~83岁),左眼9例、右眼10例,原发17例、继发2例。
  • 临床表现包括眼球突出16例、眼球运动受限14例、眼睑肿胀15例、眼睑下垂4例、眼眶肿胀疼痛11例、眼眶内压力阳性10例、结膜充血水肿9例、流泪5例、复视4例及视力下降3例。
  • 影像学示眼眶不规则软组织密度影、浸润性生长,3例侵及上颌窦或鼻腔鼻窦,6例影像学考虑良性病变;肿瘤最大直径2.2(1.0,3.0)cm(范围0.6~5.0 cm)。
  • 组织学分型中心母细胞型15例、免疫母细胞型4例;Hans分型非生发中心型13例、生发中心型6例;免疫组化Bcl-2阳性16例、C-MYC阳性11例、双表达9例、CD30阳性3例、P53阳性11例、Ki67≥80%者13例。
  • 16例随访2~48个月,10例生存、6例死亡,1例随访2个月后出现肺部转移;8例接受R-CHOP方案治疗2~9个疗程,3例完全缓解、4例部分缓解、1例治疗无效死亡。

关键数值与推荐

  • Hans分型:非生发中心型13例,生发中心型6例。
  • 免疫组化:Bcl-2阳性16例,C-MYC阳性11例,Bcl-2和C-MYC双表达9例,CD30阳性3例,P53阳性11例,Ki67≥80%者13例。
  • R-CHOP方案治疗8例,2~9个疗程,完全缓解3例、部分缓解4例、治疗无效死亡1例。

临床怎么用

  • 对眼眶占位伴眼球突出、眼睑肿胀及眼球运动受限者,应警惕O-DLBCL并行病理及免疫组化检查。
  • 病理报告应包含Hans分型、Ki67及Bcl-2/C-MYC双表达状态,以辅助判断预后。
  • 确诊后需积极治疗,R-CHOP方案为可选方案之一。

局限性

  • 为单中心回顾性病例系列研究,样本量19例,随访16例,可能存在选择偏倚。
  • 原文未报告Fisher精确概率法分析的具体比较结果及P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical and histopathological characteristics of orbital diffuse large B-cell lymphoma (O-DLBCL). Methods: It was a retrospective case series study. The clinical data of patients diagnosed with O-DLBCL in Xi'an People's Hospital (Xi'an Fourth Hospital) and Shaanxi Eye Hospital from January 2016 to December 2024 were included. The clinical manifestations, imaging and pathological characteristics of the patients were collected. Immunohistochemical indicators such as CD20, C-MYC, CD10, Bcl-2, Bcl-6, MUM1, P53 and CD30 were detected by immunohistochemistry EnVision method, and they were typed according to the Hans method. Fisher's exact probability method was used for data analysis. Results: A total of 19 patients (19 eyes) were included, including 9 males and 10 females. The median age was 56.0 (50.3, 63.0) years, and the range was 30~83 years. There were 9 cases in the left eye and 10 cases in the right eye. Among them, 17 cases were primary O-DLBCL and 2 cases were secondary O-DLBCL. The clinical manifestations of the patients included exophthalmos in 16 cases, eye movement restriction in 14 cases, eyelid swelling in 15 cases, eyelid drooping in 4 cases, orbital swelling and pain in 11 cases, positive intraorbital pressure in 10 cases, conjunctival hyperemia and edema in 9 cases, lacrimation in 5 cases, diplopia in 4 cases, and visual acuity loss in 3 cases. Imaging manifestations showed irregular soft tissue density shadows in the orbit, infiltrative growth, invasive growth that could invade surrounding soft tissues or orbital bones, 3 cases invaded the maxillary sinuses or nasal sinuses, and 6 patients were considered benign lesions on imaging. The median maximum diameter of tumors was 2.2 (1.0, 3.0) cm, and the range was 0.6-5.0 cm. 5 cases involved the lacrimal glands, 2 cases involved the eyelids, 15 cases were histologically typed as centroblasts, and 4 cases were immunoblasts; According to the Hans typing method, there were 13 cases of non-erminal center b-cell-like (non-GCB) type and 6 cases of GCB type. Immunohistochemistry showed that 16 patients were positive for Bcl-2, 11 cases were positive for C-MYC, 9 cases were co-expressed for Bcl-2 and C-MYC, 3 cases were positive for CD30, 11 cases were positive for P53, and 13 cases had a high proliferation index (Ki67≥80%). All 19 patients underwent intraorbital mass resection, of which 8 were partial mass resection, 11 cases were complete mass resection, and 3 patients underwent intranasal or intramaxillary sinus mass resection at the same time. 16 patients were followed up for 2~48 months, of which 10 patients survived, 6 patients died, 1 case developed lung metastasis after 2 months of follow-up, and the rest did not have lymphoma from other sites. There are 8 patients treated with R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine combined with prednisone) for 2~9 courses, of which 3 cases had complete remission, 4 cases had partial remission, and 1 case died after treatment. Conclusion: O-DLBCL is mostly a centroblastic type and a non-GCB type, with high Ki67 and high dual expression ratios of Bcl-2 and C-MYC, and should be actively treated to reduce its mortality rate. 目的: 探讨眼眶弥漫大B细胞淋巴瘤(O-DLBCL)的临床及组织病理学特征。 方法: 回顾性病例系列研究。纳入2016年1月至2024年12月在西安市人民医院(西安市第四医院)陕西省眼科医院确诊的O-DLBCL患者的临床资料。收集其临床表现、影像学及病理学特征,采用免疫组织化学EnVision法检测CD20、C-MYC、CD10、Bcl-2、Bcl-6、MUM1、P53及CD30等免疫组织化学指标,根据Hans法对其进行分型。采用Fisher精确概率法进行数据分析。 结果: 共纳入患者19例(19只眼),其中男性9例,女性10例;年龄为56.0(50.3,63.0)岁,范围为30~83岁;左眼9例,右眼10例。其中原发性O-DLBCL 17例,继发性O-DLBCL 2例。患者临床表现包括眼球突出16例、眼球运动受限14例、眼睑肿胀15例、眼睑下垂4例、眼眶肿胀疼痛11例、眼眶内压力阳性10例、结膜充血水肿9例、流泪5例、复视4例及视力下降3例。影像学表现为眼眶不规则软组织密度影,浸润性生长,可侵及周围软组织或眶骨,3例侵及上颌窦或鼻腔鼻窦,6例患者影像学考虑为良性病变。肿瘤最大直径为2.2(1.0,3.0)cm,范围为0.6~5.0 cm。5例累及泪腺,2例累及眼睑,组织学分型中心母细胞型15例,免疫母细胞型4例;Hans分型非生发中心型13例,生发中心型6例;免疫组织化学Bcl-2阳性16例,C-MYC阳性11例,Bcl-2和C-MYC双表达9例,CD30阳性3例,P53阳性11例,高增殖指数(Ki67≥80%)13例。19例患者均行眶内肿物切除术,其中8例为部分肿物切除,11例为肿物完整切除,3例同时行鼻内或上颌窦内肿物切除术。16例患者获得随访,随访时间2~48个月,其中10例患者生存,6例患者死亡,1例随访2个月后出现肺部转移,其余均未出现其他部位淋巴瘤,接受R-CHOP方案(利妥昔单抗、环磷酰胺、多柔比星、长春新碱联合泼尼松)治疗的患者8例,治疗2~9个疗程,其中3例完全缓解,4例部分缓解,1例治疗无效死亡。 结论: O-DLBCL多为中心母细胞型及非生发中心型,Ki67较高,Bcl-2和C-MYC双表达比率较高,需积极治疗以降低其病死率。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu H, Ren YJ, Chen YM, et al. [Clinical and histopathological characteristics of 19 cases of orbital diffuse large B-cell lymphoma]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 41491512. doi:10.3760/cma.j.cn112142-20250416-00188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。